Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study.
Hudis C, Fornier M, Riccio L, Lebwohl D, Crown J, Gilewski T, Surbone A, Currie V, Seidman A, Reichman B, Moynahan M, Raptis G, Sklarin N, Theodoulou M, Weiselberg L, Salvaggio R, Panageas KS, Yao TJ, Norton L. Hudis C, et al. Among authors: salvaggio r. J Clin Oncol. 1999 Apr;17(4):1118. doi: 10.1200/JCO.1999.17.4.1118. J Clin Oncol. 1999. PMID: 10561169 Clinical Trial.
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.
Seidman AD, Hochhauser D, Gollub M, Edelman B, Yao TJ, Hudis CA, Francis P, Fennelly D, Gilewski TA, Moynahan ME, Currie V, Baselga J, Tong W, O'Donaghue M, Salvaggio R, Auguste L, Spriggs D, Norton L. Seidman AD, et al. Among authors: salvaggio r. J Clin Oncol. 1996 Jun;14(6):1877-84. doi: 10.1200/JCO.1996.14.6.1877. J Clin Oncol. 1996. PMID: 8656256 Clinical Trial.
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Fornier MN, Seidman AD, Theodoulou M, Moynahan ME, Currie V, Moasser M, Sklarin N, Gilewski T, D'Andrea G, Salvaggio R, Panageas KS, Norton L, Hudis C. Fornier MN, et al. Among authors: salvaggio r. Clin Cancer Res. 2001 Dec;7(12):3934-41. Clin Cancer Res. 2001. PMID: 11751485 Clinical Trial.
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.
Daly B, Nicholas K, Flynn J, Silva N, Panageas K, Mao JJ, Gazit L, Gorenshteyn D, Sokolowski S, Newman T, Perry C, Wagner I, Zervoudakis A, Salvaggio R, Holland J, Chiu YO, Kuperman GJ, Simon BA, Reidy-Lagunes DL, Perchick W. Daly B, et al. Among authors: salvaggio r. JAMA Netw Open. 2022 Mar 1;5(3):e221078. doi: 10.1001/jamanetworkopen.2022.1078. JAMA Netw Open. 2022. PMID: 35244701 Free PMC article.
Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy.
Daly B, Nicholas KJ, Flynn J, Panageas KS, Silva N, Duck E, Zervoudakis A, Holland J, Salvaggio R, Begue A, Wagner I, Sokolowski S, Zablocki M, Chiu YO, Kuperman GJ, Simon BA, Perchick W, Reidy-Lagunes DL. Daly B, et al. Among authors: salvaggio r. JCO Oncol Pract. 2022 Dec;18(12):e1935-e1942. doi: 10.1200/OP.22.00294. Epub 2022 Oct 20. JCO Oncol Pract. 2022. PMID: 36265089 Free PMC article.
Oncology Clinicians' Perspectives of a Remote Patient Monitoring Program: A Multi-Modal Case Study Approach.
Mazzella-Ebstein AM, Daly R, Huang J, Bernal C, Wilhelm C, Panageas KS, Holland J, Salvaggio R, Ackerman J, Cracchiolo J, Kuperman G, Mao J, Begue A, Barton-Burke M. Mazzella-Ebstein AM, et al. Among authors: salvaggio r. JMIR Hum Factors. 2024 Sep 23. doi: 10.2196/60585. Online ahead of print. JMIR Hum Factors. 2024. PMID: 39446017 Free article.
Misery Loves Company: Presenting Symptom Clusters to Urgent Care by Patients Receiving Antineoplastic Therapy.
Daly B, Nicholas K, Gorenshteyn D, Sokolowski S, Gazit L, Adams L, Matays J, Katzen LL, Chiu YO, Xiao H, Salvaggio R, Baldwin-Medsker A, Chow K, Nelson J, Ross M, Ng KK, Zervoudakis A, Perchick W, Reidy DL, Simon BA, Wagner I. Daly B, et al. Among authors: salvaggio r. J Oncol Pract. 2018 Aug;14(8):e484-e495. doi: 10.1200/JOP.18.00199. Epub 2018 Jul 17. J Oncol Pract. 2018. PMID: 30016125 Free PMC article.
Digitally Enabled Transitional Care Management in Oncology.
Daly B, Cracchiolo J, Holland J, Ebstein AM, Flynn J, Duck E, Moy M, Walters CB, Giacomazzo L, Huang J, Fahy R, Bernal C, Ackerman J, Salvaggio R, Begue A, Raj N, Kuperman G, Mao JJ, Panageas K. Daly B, et al. Among authors: salvaggio r. JCO Oncol Pract. 2024 May;20(5):657-665. doi: 10.1200/OP.23.00565. Epub 2024 Feb 21. JCO Oncol Pract. 2024. PMID: 38382002
InSight Care Pilot Program: Redefining Seeing a Patient.
Daly B, Kuperman G, Zervoudakis A, Baldwin Medsker A, Roy A, Ro AS, Arenas J, Yanamandala HV, Kottamasu R, Salvaggio R, Holland J, Hirsch S, Walters CB, Lauria T, Chow K, Begue A, Rozenshteyn M, Zablocki M, Dhami AK, Silva N, Brown E, Katzen LL, Chiu YO, Perry C, Sokolowski S, Wagner I, Veach SR, Grisham RN, Dang CT, Reidy-Lagunes DL, Simon BA, Perchick W. Daly B, et al. Among authors: salvaggio r. JCO Oncol Pract. 2020 Oct;16(10):e1050-e1059. doi: 10.1200/OP.20.00214. Epub 2020 May 29. JCO Oncol Pract. 2020. PMID: 32468925 Free PMC article.
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment.
Daly B, Gorenshteyn D, Nicholas KJ, Zervoudakis A, Sokolowski S, Perry CE, Gazit L, Baldwin Medsker A, Salvaggio R, Adams L, Xiao H, Chiu YO, Katzen LL, Rozenshteyn M, Reidy-Lagunes DL, Simon BA, Perchick W, Wagner I. Daly B, et al. Among authors: salvaggio r. JCO Clin Cancer Inform. 2020 Mar;4:275-289. doi: 10.1200/CCI.19.00104. JCO Clin Cancer Inform. 2020. PMID: 32213093 Free PMC article.
13 results